These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23619962)

  • 1. Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre.
    Giusti M; Caorsi V; Mortara L; Caputo M; Monti E; Schiavo M; Bagnara MC; Minuto F; Bagnasco M
    Endocrine; 2014 Mar; 45(2):221-9. PubMed ID: 23619962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
    Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
    Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
    Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human thyrotropin stimulation prior to
    Azorín Belda MJ; Martínez Caballero A; Figueroa Ardila GC; Martínez Ramírez M; Gómez Jaramillo CA; Dolado Ardit JI; Verdú Rico J
    Rev Esp Med Nucl Imagen Mol; 2017; 36(1):7-12. PubMed ID: 27422154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose.
    Massaro F; Vera L; Schiavo M; Lagasio C; Caputo M; Bagnasco M; Minuto F; Giusti M
    J Endocrinol Invest; 2007 Apr; 30(4):318-22. PubMed ID: 17556869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
    Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
    Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin.
    Rubio IG; Silva MN; Knobel M; Romão R; Possato R; Gebrin EM; Buchpiguel C; Medeiros-Neto G
    J Endocrinol Invest; 2007; 30(7):535-40. PubMed ID: 17848834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre.
    Cubas ER; Paz-Filho GJ; Olandoski M; Goedert CA; Woellner LC; Carvalho GA; Graf H
    Int J Clin Pract; 2009 Apr; 63(4):583-90. PubMed ID: 18803554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.
    Nieuwlaat WA; Huysmans DA; van den Bosch HC; Sweep CG; Ross HA; Corstens FH; Hermus AR
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3121-9. PubMed ID: 12843153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
    Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
    Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies.
    Rubio IG; Perone BH; Silva MN; Knobel M; Medeiros-Neto G
    Thyroid; 2005 Feb; 15(2):134-9. PubMed ID: 15753672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.
    Fast S; Hegedüs L; Pacini F; Pinchera A; Leung AM; Vaisman M; Reiners C; Wemeau JL; Huysmans DA; Harper W; Rachinsky I; de Souza HN; Castagna MG; Antonangeli L; Braverman LE; Corbo R; Düren C; Proust-Lemoine E; Marriott C; Driedger A; Grupe P; Watt T; Magner J; Purvis A; Graf H
    Thyroid; 2014 Apr; 24(4):727-35. PubMed ID: 24341527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.
    Fast S; Nielsen VE; Bonnema SJ; Hegedüs L
    Eur J Endocrinol; 2009 Apr; 160(4):517-28. PubMed ID: 19106244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human thyrotropin (rhTSH)-aided radioiodine treatment for non-toxic multinodular goitre.
    Huo Y; Xie J; Chen S; Wang H; Ma C
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD010622. PubMed ID: 34961921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter.
    Giusti M; Caputo M; Calamia I; Bagnara M; Ceresola E; Schiavo M; Mussap M; Ferone D; Minuto F; Bagnasco M
    Thyroid Res; 2009 Jun; 2(1):6. PubMed ID: 19566933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
    Bonnema SJ; Nielsen VE; Hegedüs L
    Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtle changes in serum thyrotrophin (TSH) and sex-hormone-binding globulin (SHBG) levels during long-term follow-up after radioactive iodine in multinodular non-toxic goitre.
    Jarløv AE; Faber J; Hegedüs L; Hansen JM
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):335-7. PubMed ID: 1483288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human thyrotropin before (131)I therapy in patients with nodular goitre: a meta-analysis of randomized controlled trials.
    Lee YY; Tam KW; Lin YM; Leu WJ; Chang JC; Hsiao CL; Hsu MT; Hsieh AT
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):702-10. PubMed ID: 25370124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.